This is a preview of subscription content, access via your institution.
References
April PA, Curran NJ, Ekholm BP, Doucette ML, Wilson RR, et al. Multicenter comparative study of salsalate (SSA) vsaspirin (ASA) in rheumatoid arthritis (RA). Abstract. Arthritis and Rheumatism 30: S93, 1987
Bland J. Absorption of enteric coated aspirin Correspondence. Journal of the American Medical Association 249: 59, 1983
Blechman WJ, Lechner DL. Clinical comparative evaluation of choline magnesium trisalicylate and aspirin in RA. Rheumatology and Rehabilitation 18: 119–124, 1979
Chudwin DS, Strub M, Golden HE, Frey C, Richmond GW, et al. Sensitivity to non-acetylated salicylates in a patient with asthma, nasal polyps and rheumatoid arthritis. Annals of Allergy 57: 133–134, 1986
Dunn M. The role of arachidonic acid metabolites in renal homeostasis: non-steroidal anti-inflammatory drugs, renal function, and biochemical histological and clinical effects and drug interactions. Drugs 33 (Suppl. 1): 56–66, 1987
Estes D, Kaplan K. Lack of platelet effect with aspirin analog, salsalate. Arthritis and Rheumatism 23: 1303–1307, 1980
Fassett WE. Gastrointestinal intolerance to anti-inflammatory drugs: is salsalate an exception? Practical Gastroenterology VIII (5), 1984
Gurwich EL, Raees SM, Skosey J, Niazi S. Unbound plasma sali-cylate concentration in rheumatoid arthritis patients. British Journal of Rheumatology 23: 66–73, 1984
Harter JG. FDA drug review perspective. Presented at ‘The Terrible Twosome: NSAIDs & Ulcers’ Symposium, 49th Annual American Rheumatism Association Meeting, Anaheim, USA, June, 1985
Isselbacher KJ. The role of arachidonic acid metabolites in gastrointestinal effects. Drugs 33 (Suppl. 1): 38–46, 1987
Langman MJS. Anti-inflammatory drug intake and the risk of ulcer complications. Medical Toxicology 1 (Suppl. 1): 34–38, 1986
McCarty DJ, Csuka ME. Aspirin in the treatment of chronic inflammatory arthritis. Correspondence. Journal of the American Medical Association 257: 1331, 1987
McPherson TC. Salsalate use for arthritis: a clinical evaluation. Clinical Therapeutics 6: 388–390, 1984
Mielants H, Veys EM, Verbruggen G, Schelstraet K. Salicylate-induced gastrointestinal bleeding: comparison between soluble, buffered enteric-coated, and intravenous administration. Journal of Rheumatology 6: 210–218, 1979
Morris HG, Sherman NA, McQuain C, Goldlust MB, Chang SF, et al. Effects of salsalate (non-acetylated salicylate) and aspirin on serum prostaglandins in humans. Therapeutic Drug Monitoring 7: 435–438, 1985
Needs CJ, Brooks PM. Clinical pharmacokinetics of the salicylates. Clinical Pharmacokinetics 10: 164–177, 1985
Pleskow WW, Stevenson DD, Mathison DA, Simon RA. Aspirin sensitivity in rhinosinusitis and asthma: spectrum of adverse reactions to aspirin. Journal of Allergy and Clinical Immunology 71: 574–579 1983
Roth SH. Salicylates: revolution versus evolution. In New directions in arthritis therapy, pp. 23–26, PSG Publishing, Littleton, 1980a
Roth SH. New directions via molecular modification in NSAIDs. In New directions in arthritis therapy, pp. 59–98, PSG Publishing, Littleton, 1980b
Roth SH. Salicylates. In Roth (Ed.) Rheumatic therapeutics, pp. 309–323, McGraw-Hill, New York, 1985
Roth SH. NSAID gastropathy. We started it — can we stop it? Editorial. Archives of Internal Medicine 146: 1075, 1986a
Roth SH. Treating arthritis and sparing the stomach: the NSAID gastropathy dilemma. Arthritis and Rheumatism 8: 78–83, 1986b
Roth SH. Salicylates. In Katz (Ed.) Management of rheumatic disease, 2nd ed., Lippincott, Philadelphia, in press, 1987
Roth SH, Agrawal N, Mahowald M, Montoya H, Robbins D. Misoprostol heals aspirin-induced gastropathy in rheumatoid arthritis. Presented at the 51st Annual American Rheumatism Association meeting, Washington DC, June, 1987. Abstract. Arthritis and Rheumatism 30 (Suppl.), 1987
Roth SH, Bennett RE. Nonsteroidal anti-inflammatory drug gastropathy: recognition and response. Archives of Internal Medicine 147: 2093–2100, 1987
Russell AS, Sturge RA, Smith MA. Serum transaminases during salicylate therapy. British Medical Journal 2: 428, 1971
Ryan JR, McMahon FG, Vargas R. Differential influences of salsalate, aspirin and naproxen on plasma renin activity and platelet thromboxane synthesis. Abstract. 2nd International Meeting on Side Effects of Anti-Inflammatory Analgesic Drugs, Cambridge, England, July, 1985
Samter M. Intolerance to aspirin. Hospital Practice 50: 92–98, 1973
Samter M, Beers FR. Concerning the nature of intolerance to aspirin. Journal of Allergy 40: 218–293, 1967
Szczeklik A, Gryglewski RG, Czerniawska-Mysik G. Clinical patterns of hypersensitivity to non-steroidal anti-inflammatory drugs and their pathogenesis. Journal of Allergy and Clinical Immunology 60: 276–284, 1977
Vane J. The evolution of non-steroidal anti-inflammatory drugs and their mechanisms of action. Drugs 33 (Suppl. 1): 18–27, 1987
Voltin RF. NSAIDs from a GI point of view. Practical Gastroenterology VIII (4), 1984
Weissmann G. Pathogenesis of inflammation: effects of the pharmacological manipulation of arachidonic acid metabolism on the cytological response to inflammatory stimuli. Drugs 33 (Suppl. 1): 28–37, 1987
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Roth, S.H. Salicylates Revisited. Drugs 36, 1–6 (1988). https://doi.org/10.2165/00003495-198836010-00001
Published:
Issue Date:
DOI: https://doi.org/10.2165/00003495-198836010-00001